Suppr超能文献

原发性高血压患者对血管紧张素受体阻滞剂坎地沙坦血压反应的预测因素

Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.

作者信息

Canzanello Vincent J, Baranco-Pryor Evelyn, Rahbari-Oskoui Frederic, Schwartz Gary L, Boerwinkle Eric, Turner Stephen T, Chapman Arlene B

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.

出版信息

Am J Hypertens. 2008 Jan;21(1):61-6. doi: 10.1038/ajh.2007.24.

Abstract

BACKGROUND

Response to antihypertensive drugs varies widely among individuals.

METHODS

We studied characteristics that might be predictive of blood pressure (BP) response in 203 African-American and 236 non-Hispanic white subjects with essential hypertension treated with candesartan, 32 mg/day for 6 weeks, after a drug-free washout period of at least 4 weeks (baseline). Measurements at enrollment, baseline, and at the end of the treatment were incorporated into linear regression models to quantify their additive contributions to predicting response.

RESULTS

Enrollment measurements predictive of a greater response were non-Hispanic white ethnicity, female gender, the interaction between ethnicity and gender, and lower body weight. Of baseline measurements, higher BP and higher plasma renin activity (PRA) made additional contributions to predicting a greater response. Of the measurements made at the end of the study, only a larger increase in PRA from baseline contributed to predicting a greater response. The combined effects of all the identified predictors accounted for 39 and 33% of the interindividual variation in systolic and diastolic BP responses, respectively (P < 0.001 for both).

CONCLUSIONS

These results indicate that easily determined characteristics such as ethnicity, gender, body weight, as well as pretreatment levels of BP and PRA predict a substantial fraction of the BP response to candesartan and support the notion that characteristics associated with a poor response to diuretic therapy are associated with better responses to an angiotensin receptor blocker (ARB).

摘要

背景

个体对降压药物的反应差异很大。

方法

我们研究了203名非裔美国人和236名非西班牙裔白人原发性高血压患者在至少4周的无药洗脱期(基线期)后,接受坎地沙坦32毫克/天治疗6周时,可能预测血压(BP)反应的特征。将入组时、基线期和治疗结束时的测量值纳入线性回归模型,以量化它们对预测反应的累加贡献。

结果

预测反应较大的入组测量值为非西班牙裔白人种族、女性性别、种族与性别的相互作用以及较低体重。基线测量值中,较高的血压和较高的血浆肾素活性(PRA)对预测较大反应有额外贡献。在研究结束时进行的测量中,只有从基线期起PRA的较大升高对预测较大反应有贡献。所有已确定预测因素的综合效应分别占收缩压和舒张压反应个体间变异的39%和33%(两者P均<0.001)。

结论

这些结果表明,种族、性别、体重等易于确定的特征,以及血压和PRA的治疗前水平可预测对坎地沙坦的血压反应的很大一部分,并支持这样一种观点,即与利尿剂治疗反应不佳相关的特征与对血管紧张素受体阻滞剂(ARB)的较好反应相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验